DOC Stock Analysis: Buy, Sell, or Hold?
DOC - Healthpeak Properties, Inc.
$16.55
-0.04 (-0.24%)
βΌ
5d:
-3.61%
30d:
-6.39%
90d:
+2.73%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Apr 23, 2026
22d
Get Alerted When DOC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π HOLD: DOC is fairly valued with market pricing in 3.0% annual growth. Fine to hold or accumulate slowly on dips.
π HOLD: DOC is fairly valued with market pricing in 3.0% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.28
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$3.90
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DOC is currently trading at $16.55, which is considered oversold relative to its 30-day fair value range of $16.89 to $17.56. The stock's valuation (Forward PE: 82.8) is in line with its historical norms (75.7). At these levels, the market is pricing in 3.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DOC is showing sideways momentum. The price is currently testing key support at $16.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DOC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.88 (+20.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DOC is showing sideways momentum. The price is currently testing key support at $16.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DOC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.88 (+20.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$16.89 -
$17.56
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.1% below Wall St target ($19.88)
- NEUTRAL: Market pricing in 3.0% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$16.89 -
$17.56
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$16.46
Resistance Level
$17.85
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
82.75
Wall Street Target
$19.88
(+20.1%)
Revenue Growth (YoY)
3.1%
Earnings Growth (YoY)
2448.4%
Profit Margin
2.5%
Valuation Premium vs History
+3.0% premium
PE vs Historical
82.8 vs 75.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$17.05
(+3%)
2-Year Target
$17.56
(+6%)
3-Year Target
$18.08
(+9%)
3-Yr Target (if PE normalizes)
(PE: 83β76)
PE COMPRESSION
$16.54
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 82.8, Growth: 5.3%)
$19.30
(+17%)
Base:
(SPY PE: 22.4, Growth: 5.3%)
$5.21
(-69%)
Bear:
(PE: 19.0, Growth: 5.3%)
$4.43
(-73%)
π
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (114x PE), but valuation improves significantly next year (83x PE) as earnings recover.
Forward PE: 113.64 | Forward EPS (Implied): $0.15
Bull Case
$20.73
(+21%)
Analyst growth 15.0%, PE expands to 119.3
Base Case
$17.17
(0%)
Market implied 0.0%, PE stable at 113.6
Bear Case
$13.14
(-24%)
Severe decline -15.0%, PE contracts to 102.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: March 31, 2026 1:26 AM ET
Data refreshes hourly during market hours. Next update: 2:26 AM
Data refreshes hourly during market hours. Next update: 2:26 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DOC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Gilbert Ray Cisneros, Jr.
SELL
2026-02-10
Gilbert Ray Cisneros, Jr.
BUY
2026-01-09
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$92 | 61 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$229 | 53 HOLD |
|
AHR
American Healthcare REIT⦠|
STRONG BUY
9 analysts |
$58 | 59 HOLD |
|
STRW
Strawberry Fields REIT L⦠|
STRONG BUY
7 analysts |
$15 | 57 HOLD |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
9 analysts |
$44 | 60 HOLD |